Expert: Jennifer Surtees, PhD, associate professor of biochemistry in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. Surtees and her colleagues at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences have…
Researchers Develop More Reliable Rapid Tests for COVID-19
Public Release Date: 15-Jun-2021 00:00:00 US Eastern Time (24hr)
Research News Release
Contact Person: Deborah Kotz
Contact Phone: 410-706-4255
Contact E-mail: [email protected]
Journal: Nature Protocols
Medicine/Health -> Diagnostics
Medicine/Health -> Infectious/Emerging Diseases
Tests Use Innovative Techniques That Improve Accuracy Rivaling Gold Standard PCR Test
Researchers at the University of Maryland School of Medicine (UMSOM) have developed two rapid diagnostic tests for COVID-19 that are nearly as accurate as the gold-standard test currently used in laboratories. Unlike the gold standard test, which extracts RNA and uses it to amplify the DNA of the virus, these new tests can detect the presence of the virus in as little as five minutes using different methods.
The number of COVID-19 variants is growing rapidly, so much that the scale and scope of mutation may pose a threat to the continuing successful use of the current vaccines and therapies. The findings, by an international team that includes University of California researchers, are being published in the June edition of the peer-reviewed journal EMBO Molecular Medicine. The pace of variation of the SARS-CoV-2 virus strains makes plain the threat that rapidly evolving new strains might give rise to escape variants, capable of limiting the efficacy of vaccines, therapies, and diagnostic tests.
The Southwest National Primate Research Center (SNPRC) at Texas Biomed has been awarded more than $37 million from the National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
People with health insurance are receiving the COVID-19 vaccine at a higher rate than those without insurance, despite the vaccine being free, according to a national survey from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University-New Brunswick.
This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.
Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.
More physical activity programming could mitigate the effects of stress and improve worker mental and emotional health.
The CSU pledges to be a Vaccine Champion University as part of new White House effort aimed at increasing vaccinations for younger Americans.
• The virus that causes COVID-19 can infect and replicate in human kidney cells, but this does not typically lead to cell death.
• Kidney cells that already have features of injury may be more easily infected and develop additional injury.
New findings include a significant increase in risk of death among patients who had recently had chemotherapy.
National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination.
• Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.
• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.
In a new study published in Nature, Dan Barouch, MD, PhD, Director of BIDMC’s Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.
Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.
A new study based on evidence from Germany and on a model of the dynamic nature of people’s resistance to COVID-19 vaccination sounds an alarm: mandating vaccination could have a substantial negative impact on voluntary compliance.
Studies being presented at NUTRITION 2021 LIVE ONLINE bring new insights into how people ate, shopped and felt about food as the COVID-19 pandemic unfolded. Studying these trends can shed light on potential lingering health impacts of the pandemic and inform responses to future emergencies.
As COVID-19 spread throughout the world, our daily routines and behaviors changed drastically. A new study of more than 2,000 people in the U.S. found that the pandemic has also affected how we eat. The authors found a decrease in the consumption of many food groups, particularly healthy foods such as vegetables and whole grains, compared to before the pandemic.
Researchers at the Helsinki Graduate School of Economics have found that the Pfizer-BioNTech and Moderna Covid-19 vaccines protect both vaccinated individuals and their unvaccinated adult household members against SARS-CoV-2 infections. The study, not yet peer-reviewed, used Finnish administrative datasets to examine the link between mRNA-based Covid-19 vaccines and infection risk among vaccinated individuals as well as their unvaccinated family members.
As vaccination rates increase and prospects of normal life return more than a year into the coronavirus pandemic, New Jerseyans differ on various aspects of this “new normal” and how comfortable they feel, according to the latest Rutgers-Eagleton Poll.
Reporting at the 2021 annual meeting of the American Society of Clinical Oncology, Kathryn A. Gold, MD, associate clinical professor at University of California San Diego School of Medicine, presented data showing a decrease in people diagnosed with early stage…
A high percentage of the population may experience “re-entry anxiety” as more people get vaccinated, guidelines are loosened and the masks come off, according to WVU psychologists.
• Among adults with kidney failure undergoing hemodialysis in New York City, Black and Hispanic patients were more likely to develop symptomatic COVID-19 than White patients.
• Neighborhood-level social vulnerability factors were associated with COVID-19 incidence among White patients, but these factors did not explain racial/ethnic disparities.
This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.
A Cleveland Clinic study shows that survivors of COVID-19 who have moderate or severe obesity may have a greater risk of experiencing long-term consequences of the disease, compared with patients who do not have obesity. The study was recently published online in the journal of Diabetes, Obesity and Metabolism.
Seventy-three percent of New Jerseyans say they have received at least one dose of a COVID-19 vaccine, and while another 10 percent say they will likely roll up their sleeve for it, 16 percent remain unwilling, according to the latest Rutgers-Eagleton Poll.
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.
SEATTLE — June 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. If you are covering news at the annual meeting of the American Society of Clinical Oncology (June 4-8), check out our ASCO page highlighting Fred Hutch presentations and feel free to reach out to our media team for help sourcing experts: [email protected]
The American Autoimmune Related Disease Association (AARDA) hosted the 15th Noel Rose Scientific Colloquium on May 1, 2021, bringing together high-level researchers from different areas and specialties.
• Among individuals with kidney failure who received dialysis at clinics several times each week, COVID-19 risks were higher in patients who were older, had diabetes, lived in local communities with higher COVID-19 rates, and received dialysis at clinics that served a larger number of patients.
• Risks were lower in patients who received dialysis in clinics with a higher number of available side rooms and that had mask policies for asymptomatic patients.
A small molecule STING agonist was highly protective against the virus that causes COVID-19 and likely other coronaviruses
Colchicine could be considered as a treatment for non-hospitalized patients diagnosed with COVID-19 by PCR test and at risk of complications
COLUMBUS, Ohio – A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.
Houston Methodist announced today, in partnership with the U.S. Department of Health and Human Services (HHS), that it has expanded access to COVID-19 monoclonal antibody therapy (mAb) in the Greater Houston area. The promising treatment has been shown to keep high-risk COVID-19 patients out of the hospital and reduce the likelihood of progression to severe disease.
More than 70% of K-12 students across the country experienced some remote schooling during the 2020-21 school year, with stark differences emerging along regional and racial lines and the worst effects on students’ social relationships, according to a new, nationally representative study conducted by Ipsos, using its KnowledgePanel, for the Tufts University Research Group on Equity in Health, Wealth and Civic Engagement.
As many as one in three COVID-19 survivors experience a mental health or neurological disorder, adding to a growing body of evidence that show COVID-19 can have serious and potentially long-lasting effects on the brain. The Penn Neuro COVID Clinic aims to assess and treat long-haul COVID patients suffering from neurological symptoms.
A new study from Washington University School of Medicine in St. Louis suggests that, among men, low testosterone levels in the blood are linked to more severe COVID-19. The study contradicts widespread assumptions that higher testosterone may explain why men, on average, develop more severe COVID-19 than women do.
Expanded program will be available to NYC schools and other organizations
Mental health includes our emotional, psychological, and social well-being. Checkout the strategies for improving your mental health & emotional well-being.
Neelima Navuluri, MD, of Duke University has been awarded the ATS/Mallinckrodt Research Grant on COVID-19 in Underrepresented Minorities.
In a new report published in the Journal of Infectious Diseases, the 11-member Data and Safety Monitoring Board (DSMB) that is overseeing the federally funded COVID-19 vaccine trials outlines its mission, procedures, and the challenges that it faced in monitoring…
As people with long-haul COVID-19 continue to recover from their illness, neurocognitive symptoms may persist or even worsen over time, as reported in new findings from researchers at DePaul University.
Philadelphia-Based Top Academic Health System Becomes Nation’s Largest to Mandate Vaccination, Calling for Workforce to Set an Example to End the Pandemic
If there’s one take-home message for the general public about the coronavirus vaccines approved in the U.S., it’s that they are remarkably effective. But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for men than for women.
NEJM Group and Education Management Solutions (EMS), a Collegis Education company, have signed an agreement to put a cutting-edge clinical diagnosis training program in front of every healthcare student in the United States.
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH’s Community Engagement Alliance (CEAL) Against COVID-19 Disparities. The Philly CEAL team was awarded $1.4 million from the NIH with additional support from Penn Nursing and The University of Pennsylvania, bringing the total for the alliance to $1.53 million.
White people are more likely to have been vaccinated than Black people despite similar levels of vaccine hesitancy, or saying they are very unlikely to get a vaccine. Therefore, access to vaccines and other factors could be limiting vaccination efforts, according to a new, nationally representative study from the Tufts University Research Group on Equity in Health, Wealth and Civic Engagement.
Vaccines are turning the tide of the pandemic, but there’s still a risk of COVID-19 infections. Instant at-home tests would help us return to normal, but current options aren’t very accurate. A new discovery could get reliable tests on the market.
Reporters and bloggers are invited to join top nutrition researchers and practitioners for a dynamic virtual program at NUTRITION 2021 LIVE ONLINE. The flagship meeting of the American Society for Nutrition runs June 7–10, 2021 and features research announcements, expert discussions and more.